Theclinic (SW) Ltd 11031351 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is that of human health activities. Digita Accounts Production Advanced 6.30.9574.0 true false true 11031351 2023-03-01 2024-02-29 11031351 2024-02-29 11031351 core:CurrentFinancialInstruments 2024-02-29 11031351 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 11031351 core:Non-currentFinancialInstruments 2024-02-29 11031351 core:Non-currentFinancialInstruments core:AfterOneYear 2024-02-29 11031351 bus:SmallEntities 2023-03-01 2024-02-29 11031351 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 11031351 bus:FilletedAccounts 2023-03-01 2024-02-29 11031351 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 11031351 bus:RegisteredOffice 2023-03-01 2024-02-29 11031351 bus:Director2 2023-03-01 2024-02-29 11031351 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 11031351 countries:EnglandWales 2023-03-01 2024-02-29 11031351 core:CostValuation 2023-02-28 11031351 2022-03-01 2023-02-28 11031351 2023-02-28 11031351 core:CurrentFinancialInstruments 2023-02-28 11031351 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 11031351 core:Non-currentFinancialInstruments 2023-02-28 11031351 core:Non-currentFinancialInstruments core:AfterOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 11031351

Theclinic (SW) Ltd

Unaudited Filleted Financial Statements

for the Year Ended 29 February 2024

 

Theclinic (SW) Ltd

Contents

Statement of Financial Position

1

Notes to the Unaudited Financial Statements

2 to 5

 

Theclinic (SW) Ltd

(Registration number: 11031351)
Statement of Financial Position as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Investments

4

230,000

230,000

Current assets

 

Debtors

5

41,057

-

Cash at bank and in hand

 

1,865

2,636

 

42,922

2,636

Creditors: Amounts falling due within one year

6

(224,017)

(177,322)

Net current liabilities

 

(181,095)

(174,686)

Total assets less current liabilities

 

48,905

55,314

Creditors: Amounts falling due after more than one year

6

(31,875)

(53,125)

Net assets

 

17,030

2,189

Capital and reserves

 

Called up share capital

1

1

Profit and loss account

17,029

2,188

Shareholders' funds

 

17,030

2,189

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the director on 18 November 2024
 


Mr S K Haderlein
Director

 

Theclinic (SW) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Stanhope House
9-10 Fore Street
Holsworthy
Devon
EX22 6DT

Principal activity

The principal activity of the company is that of human health activities.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling which is the functional currency of the entity.

Going concern

The financial statements have been prepared on a going concern basis.

 

Theclinic (SW) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024 (continued)

2

Accounting policies (continued)

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. In the statement of financial position, bank overdrafts are shown within borrowing or current liabilities

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the statement of comprehensive income over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Theclinic (SW) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024 (continued)

2

Accounting policies (continued)

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Investments

2024
£

2023
£

Investments in subsidiaries

230,000

230,000

Subsidiaries

£

Cost or valuation

At 1 March 2023

230,000

Provision

Carrying amount

At 29 February 2024

230,000

At 28 February 2023

230,000

5

Debtors

2024
£

2023
£

Other debtors

41,057

-

41,057

-

 

Theclinic (SW) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024 (continued)

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

8

21,250

21,250

Trade creditors

 

780

780

Amounts owed to group undertakings and undertakings in which the company has a participating interest

200,357

153,511

Accruals and deferred income

 

1,630

1,472

Other creditors

 

-

309

 

224,017

177,322

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

8

31,875

53,125

7

Reserves

Profit and loss account:

This reserve records retained earnings and accumulated losses.

8

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

31,875

53,125

Current loans and borrowings

2024
£

2023
£

Bank borrowings

21,250

21,250